Me-One

# Me-one ## Overview - **Classification**: Novel Broad-Spectrum Cephalosporin Antibiotic - **Mechanism**: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell lysis and death. Bactericidal. ## Primary Indications 1. **Community-Acquired Pneumonia (CAP)** - Treatment of mild to moderate CAP caused by susceptible organisms. 2. **Complicated Urinary Tract Infections (cUTI)** - Treatment of cUTI, including pyelonephritis. 3. **Skin and Soft Tissue Infections (SSTI)** - Treatment of uncomplicated SSTI caused by susceptible bacteria. ## Adult Dosing ### Standard Dosing **Community-Acquired Pneumonia (CAP) & Skin and Soft Tissue Infections (SSTI)** - **Dose**: **500 mg** - **Frequency**: Every **8 hours** - **Route**: Intravenous (IV) or Oral (PO) for step-down - **Duration**: 7-10 days, based on clinical response **Complicated Urinary Tract Infections (cUTI)** - **Dose**: **250 mg** - **Frequency**: Every **12 hours** - **Route**: Intravenous (IV) or Oral (PO) - **Duration**: 5-7 days ### Dose Adjustments - **Renal Impairment**: - **CrCl 30-60 mL/min**: Administer **50%** of standard dose or extend interval to every **12-16 hours**. - **CrCl <30 mL/min**: Administer **25%** of standard dose or extend interval to every **24 hours**. - **Hemodialysis**: Administer dose after dialysis. - **Hepatic Impairment**: No specific dose adjustment is generally required. Use with caution in severe impairment. - **Elderly Patients**: Monitor renal function closely and adjust dose as per CrCl guidelines. Increased risk of adverse effects. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **10-15 mg/kg/dose** - **Frequency**: Every **12-24 hours**, depending on post-menstrual age and postnatal age. - **Maximum**: Not to exceed **250 mg/dose**. - **Special Notes**: Use with extreme caution in preterm neonates due to immature renal function. Monitor for hyperbilirubinemia. ### Infants (1-12 months) - **Dose**: **15-20 mg/kg/dose** - **Frequency**: Every **8-12 hours** - **Maximum**: **250 mg/dose** - **Special Notes**: Oral suspension available; ensure accurate dosing with calibrated device. ### Children (1-12 years) - **Dose**: **20-30 mg/kg/dose** - **Frequency**: Every **8 hours** - **Maximum**: **500 mg/dose** or **1.5 g/day** - **Special Notes**: Avoid exceeding adult maximum daily dose. ### Adolescents (13-18 years) - **Dose**: Generally follows **adult dosing** guidelines. - **Maximum**: **1.5 g/day** (based on adult maximum dose). ## Safety Information ### Contraindications - **Absolute**: Known severe hypersensitivity to Me-one, other cephalosporins, or any beta-lactam antibiotics. - **Absolute**: History of severe immediate hypersensitivity reaction (e.g., anaphylaxis) to penicillin. - **Relative**: History of *Clostridioides difficile*-associated diarrhea (CDAD). ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea, Nausea, Headache - **Common (1-10%)**: Rash, Vomiting, Abdominal pain, Oral candidiasis - **Serious but Rare**: Anaphylaxis, Seizures, *Clostridioides difficile* infection (CDI), Stevens-Johnson Syndrome. ### Key Drug Interactions - **Warfarin**: May enhance anticoagulant effects. **Monitor INR** closely; adjust warfarin dose if needed. - **Probenecid**: Decreases Me-one renal clearance, increasing Me-one levels. **Reduce Me-one dose** if co-administered. - **Oral Contraceptives**: May reduce efficacy of hormonal contraceptives. Advise **backup birth control** methods during treatment. ## Monitoring & Follow-up - **Before Treatment**: Obtain culture and sensitivity (C&S) results. Assess baseline renal function (CrCl). - **During Treatment**: Monitor for signs of clinical improvement or worsening infection. Observe for adverse effects (e.g., rash, severe diarrhea). - **Clinical Signs**: Watch for any signs of allergic reaction (rash, dyspnea), persistent or severe diarrhea (especially with fever/blood). ## Clinical Pearls - 💡 Administer oral Me-one with food to minimize gastrointestinal upset. - 💡 Advise patients to complete the entire course of therapy, even if symptoms improve, to prevent resistance. - 💡 Counsel patients on potential for yeast infections (oral or vaginal) and appropriate management if they occur. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.